Adaptations of Brain Energy Metabolism to Hypoglycemia
脑能量代谢对低血糖的适应
基本信息
- 批准号:8535731
- 负责人:
- 金额:$ 15.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-15 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAcuteAddressAnimal ModelAnimalsAwardBasic ScienceBlood GlucoseBrainBrain InjuriesCaprylatesCarbohydratesCarbonChronicCitric Acid CycleClinicalClinical ResearchCognitionCognitiveComplications of Diabetes MellitusDataDependenceDeteriorationDevelopmentDiabetes MellitusDiabetic AngiopathiesDietDietary InterventionEnergy MetabolismEnrollmentExposure toFailureFellowshipFrightFundingGlucoseGoalsHealthHealth SciencesHormonesHumanHyperglycemiaHypoglycemiaImpaired cognitionIn Vivo NMR SpectroscopyIncidenceInfusion proceduresInjuryInsulinInsulin-Dependent Diabetes MellitusInvestigationKetone BodiesKetonesLabelLaboratoriesMeasuresMedium chain fatty acidMetabolicMetabolismMethodsMindMitochondriaNMR SpectroscopyNational Research Service AwardsNeuronsNeurosciencesPathway interactionsPatientsPerformancePhysiciansPhysiologicalPlasmaPyruvate Dehydrogenase ComplexRecurrenceRiskRouteScanningScientistStimulusSymptomsTechnologyTestingTherapeutic UsesTimeTissuesTrainingTranslatingUrsidae FamilyWorkanimal databaseblood glucose regulationbrain metabolismcareercognitive functiondiabeticdiabetic patientdiabetic ratfollow-uphuman subjecthypoglycemia unawarenessimprovedin vivomacrovascular diseasemetabolic abnormality assessmentneuroprotectionneurotransmitter metabolismnovelnovel therapeutic interventionnovel therapeuticspreventprogramspyruvate dehydrogenaseresponsetype I diabeticuptake
项目摘要
DESCRIPTION (provided by applicant): Diabetic complications can be reduced by normalization of blood glucose levels via intensive insulin therapy. This treatment, while effective, bears the risk of an increased incidence of recurrent hypoglycemia. It blunts the central counterregulatory response to low blood glucose (counterregulatory failure) and thereby magnifies the risk of severe hypoglycemia and brain injury. The overall goal of this proposal is to understand the changes in brain metabolism that underlie these phenomena and identify possible therapies in order to prevent them. We will determine the impact of a medium chain fatty acid enriched diet on brain metabolism in tightly controlled T1DM subjects with hypoglycemia unawareness and an animal model thereof. We will further test the hypothesis that chronic provision of medium chain fatty acids can improve cognitive performance under hypoglycemia in human subjects. Data gathered from our animal studies revealed a specific change of neuronal energy metabolism under hypoglycemia following exposure to antecedent recurrent hypoglycemia that make is more difficult for neurons to utilize fuels like glucose or lactate. We also found that after recurrent hypoglycemia, lactate uptake into the brain was facilitated, but because it could subsequently not be utilized by mitochondria as effectively as under control conditions, it may not be an ideal fuel. This let us to look for different alternate substrates that follow the same route of uptake as lactate, but enter metabolism via a different pathway. One group of fuels that fulfill these criteria are ketone bodies and medium chain fatty acids. Applying state of the art technologies like in vivo NMR spectroscopy to our animal model of recurrent hypoglycemia will allows us address the hypothesis that they are better suited to support metabolism. We will use this animal model to determine how diabetes confounds the adaptations induced by recurrent hypoglycemia alone and then go on to translate our findings to a clinical study of cognition and metabolism in intensively treated T1DM patients. Our work is the first step towards developing candidate molecules into novel therapies that would protect the brain from hypoglycemia induced brain injury. The projects proposed here are building on preliminary studies that I have performed during my NRSA fellowship training and since then. They will give me the ideal opportunity to continue my training in NMR spectroscopy and its application to neuroscience and diabetes related complications. Most of my training thus far has been in the use of basic science methods and animal models. Wanting to become a well trained physician scientist however I realized that I still needed more training in human investigation. To that end I enrolled in a Master of Health Sciences program to receive further training in translational methods. Funding under this career award will allow me to continue these activities and give me the protected time from clinical duties that I will need to accomplish my career goal of establishing myself as an independently funded physician-scientist, eventually with my own laboratory and workgroup.
PUBLIC HEALTH RELEVANCE: Understanding the changes of brain energy substrate transport and metabolism in intensively treated type 1 diabetic patients will provide the basis for the identification of novel therapeutic approaches that could protect the brain from hypoglycemia induced injury. This in turn could then sustain normal brain metabolism under hypoglycemia and would also allow for tighter glucose control with better protection from long-term diabetic related complications.
描述(由申请人提供):通过强化胰岛素治疗使血糖水平正常化可减少糖尿病并发症。这种治疗虽然有效,但有增加复发性低血糖发生率的风险。它减弱了中枢对低血糖的反调节反应(反调节失败),从而放大了严重低血糖和脑损伤的风险。该提案的总体目标是了解这些现象背后的大脑代谢变化,并确定可能的治疗方法以预防它们。我们将确定富含中链脂肪酸的饮食对低血糖无意识的严格控制的T1DM受试者及其动物模型的脑代谢的影响。我们将进一步检验长期提供中链脂肪酸可以改善人类受试者在低血糖情况下的认知表现的假设。从我们的动物研究中收集的数据显示,在暴露于先前复发的低血糖后,低血糖下神经元能量代谢的特定变化使得神经元更难以利用葡萄糖或乳酸等燃料。我们还发现,在反复低血糖后,促进了乳酸摄取到大脑中,但由于它随后不能像在对照条件下那样有效地被线粒体利用,因此它可能不是理想的燃料。这让我们寻找不同的替代底物,它们遵循与乳酸相同的摄取途径,但通过不同的途径进入代谢。满足这些标准的一组燃料是酮体和中链脂肪酸。将最先进的技术如体内NMR光谱应用于我们的复发性低血糖动物模型将使我们能够解决它们更适合支持代谢的假设。我们将使用该动物模型来确定糖尿病如何混淆单独由复发性低血糖诱导的适应,然后继续将我们的发现转化为强化治疗的T1DM患者的认知和代谢的临床研究。我们的工作是将候选分子开发成新疗法的第一步,该疗法将保护大脑免受低血糖引起的脑损伤。这里提出的项目是建立在我在NRSA奖学金培训期间和此后进行的初步研究的基础上。他们将给我一个理想的机会,继续我在核磁共振光谱学及其应用于神经科学和糖尿病相关并发症的培训。到目前为止,我的大部分训练都是使用基础科学方法和动物模型。想要成为一名训练有素的医生科学家,然而,我意识到我仍然需要更多的人类调查培训。为此,我参加了健康科学硕士课程,接受进一步的翻译方法培训。在这个职业奖下的资金将使我能够继续这些活动,并给我从临床职责,我将需要完成我的职业目标,建立自己作为一个独立资助的医生,科学家,最终与我自己的实验室和实验室的保护时间。
公共卫生关系:了解强化治疗的1型糖尿病患者脑能量底物转运和代谢的变化,将为确定新的治疗方法提供基础,可以保护脑免受低血糖引起的损伤。这反过来又可以在低血糖的情况下维持正常的大脑代谢,并且还可以更严格地控制血糖,更好地防止长期糖尿病相关并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raimund Ingo Herzog其他文献
Ein Polymorphismus im Intron 3 des p53-Gens und erhöhtes Risiko für Ovarialkarzinom
- DOI:
10.18725/oparu-108 - 发表时间:
2000-05 - 期刊:
- 影响因子:0
- 作者:
Raimund Ingo Herzog - 通讯作者:
Raimund Ingo Herzog
Raimund Ingo Herzog的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raimund Ingo Herzog', 18)}}的其他基金
Mechanism of ultrasound neuromodulation effects on glucose homeostasis and diabetes
超声神经调节对葡萄糖稳态和糖尿病的影响机制
- 批准号:
10586211 - 财政年份:2023
- 资助金额:
$ 15.43万 - 项目类别:
Reversing brain metabolic adaptations to recurrent hypoglycemia in older adults with type 1 diabetes using a Predictive Low Glucose Management (PLGM) system
使用预测性低血糖管理 (PLGM) 系统逆转患有 1 型糖尿病的老年人的大脑代谢适应,以应对复发性低血糖
- 批准号:
9236876 - 财政年份:2016
- 资助金额:
$ 15.43万 - 项目类别:
Human Brain Ketone Metabolism in Type 1 Diabetes and Hypoglycemia.
1 型糖尿病和低血糖中的人脑酮代谢。
- 批准号:
8622673 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
1 型糖尿病脑葡萄糖代谢的调节
- 批准号:
10379262 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism by Alternate Fuels in Type 1 Diabetes
1 型糖尿病中替代燃料对脑葡萄糖代谢的调节
- 批准号:
8818284 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Human Brain Ketone Metabolism in Type 1 Diabetes and Hypoglycemia.
1 型糖尿病和低血糖中的人脑酮代谢。
- 批准号:
8779720 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism by Alternate Fuels in Type 1 Diabetes
1 型糖尿病中替代燃料对脑葡萄糖代谢的调节
- 批准号:
9097688 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism by Alternate Fuels in Type 1 Diabetes
1 型糖尿病中替代燃料对脑葡萄糖代谢的调节
- 批准号:
9280934 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
1 型糖尿病脑葡萄糖代谢的调节
- 批准号:
9897264 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
1 型糖尿病脑葡萄糖代谢的调节
- 批准号:
10619549 - 财政年份:2014
- 资助金额:
$ 15.43万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 15.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 15.43万 - 项目类别:
Standard Grant